Latest Report on Diarrhea Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Diarrhea (Gastrointestinal), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
Key players of Diarrhea Pipeline (Gastrointestinal) A. Menarini Industrie Farmaceutiche Riunite Srl,Actelion Ltd,Aegis Therapeutics LLC,Akthelia Pharmaceuticals Ltd,Albireo Pharma Inc,AmpliPhi Biosciences Corp,Anatara Lifesciences Limited,Ardelyx Inc, Assembly Biosciences Inc,AzurRx BioPharma Inc,Bharat Biotech International Ltd, CinRx Pharma LLC, Codagenix Inc,Cosmo Pharmaceuticals NV, DesignMedix Inc, DiscoveryBiomed Inc,Genextra Spa,GlaxoSmithKline Plc,GP Pharm SA,Miyarisan Pharmaceutical Company Ltd, Mucosis BV.
Purchase This Single User License PDF Report of 146 pages at: http://www.reportsnreports.com/purchase.aspx?name=1125828
Diarrhea is a contagious gastrointestinal infection occurring mostly due to unhygienic conditions. Diarrhea may be related to a viral or bacterial infection and is sometimes the result of food poisoning. Symptoms include nausea, abdominal pain, cramping, bloating, dehydration, fever, bloody stools, frequent urge to evacuate the bowels and incontinence. Treatment includes medication and healthy lifestyle.
The Diarrhea (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Diarrhea and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical and Discovery stages are 7, 10, 2, 1, 21 and 4 respectively. Similarly, the Universities portfolio in Phase I and Preclinical stages comprises 2 and 4 molecules, respectively.
Discount is available on Diarrhea report at http://www.reportsnreports.com/contacts/discount.aspx?name=1125828
Diarrhea (Gastrointestinal) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Drug Profile: CBM-588, cholestyramine, crofelemer DR, Escherichia coli vaccine, ETEC vaccine, Etvax, ibodutant, IMSUTMR-1501, LJN-452, octreotide acetate, ORP-101 PF-06425090, prulifloxacin, PZ-7475, RBX-2660, RDX-023, Recombinant Enzyme for Diarrhea, ribaxamase, ridinilazole, rifamycin CR, Rotavac-5C, Rx-100 and more..
ReportsandReports.com is your single source for all market research needs. Our database includes 100,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.
2nd Floor, Metropole,
Bund Garden Road,
Pune – 411001,
Tel: + 1 888 391 5441